—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Teva Pharma Industries Ltd ADR (TEVA) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for TEVA, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
How it trades on rate days beta 0.20 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How TEVA has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.20 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Teva Pharma Industries Ltd ADR moved 0.20% on average · correlation 0.05 · higher than 21% of US names
  • Beta, last 3 months 0.13 about the same as over the year
  • On the 10 worst bond days +0.12% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +3.10% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Drug Manufacturers - Specialty & Generic · US · 8 names with week and year-to-date

Peer group

Drug Manufacturers - Specialty & Generic · US

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against TEVA on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Teva Pharma Industries Ltd ADR

TEVA in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Teva makes and sells generic medicines across many dosage forms alongside branded treatments for the nervous system, respiratory illness and cancer, and supplies active ingredients and contract manufacturing to other drugmakers. It licenses products to other pharmaceutical firms and has agreements with partners such as Sanofi and Alvotech. It is headquartered in Tel Aviv and lists in the United States as an ADR, a certificate that lets US investors hold foreign shares.
Where it sits in the stack
Teva has no seat in our index, Rubin, which tracks the AI build-out; it belongs to the diary's Healthcare sleeve, the part of our universe covering scored drugmakers rather than compute or chip layers.
Who it is priced against
Closelooknet's peer group places it with other scored Healthcare names based in the US, among them Regeneron, Vertex and BeiGene; the market also compares it with fellow generics maker Viatris.
Why Closelooknet tracks it
Teva carries a Closelooknet score built from several modules; momentum reads strongest, quality reads weakest. It holds no seat in our index and has not yet appeared in the diary's editions or quotes.
What the diary watches
The diary watches whether branded launches such as AJOVY and UZEDY keep offsetting pricing pressure in the generics business, since that balance feeds the quality module's read.

Teva Pharma Industries Ltd ADR (TEVA) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: price target by Oppenheimer, 2026-09-23

The Street on this name

Analyst actions and the latest print for TEVA from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target Oppenheimer — target 50 Target set to $50 (+26.5% to spot) 2026-09-23

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Teva Pharma Industries Ltd ADR (TEVA)?

Teva Pharma Industries Ltd ADR trades as TEVA on the US exchange (US) in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is TEVA in a Closelooknet index?

Not currently — Teva Pharma Industries Ltd ADR is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

Where does TEVA trade against its moving averages?

Uptrend stack intact: Trades +5% vs the 50-day and +15.9% vs the 200-day average, 4.1% below the 52-week high and +107.8% off the 52-week low. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Teva Pharma Industries Ltd ADR compare with its peers?

Against its peer group (Drug Manufacturers - Specialty & Generic · US), Teva Pharma Industries Ltd ADR (TEVA) sits 4.1% below its 52-week high, 5.0% above its 50-day average; Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is 4.2% below, Dr. Reddy’s Laboratories Ltd ADR (RDY) is 19.5% below, Hims Hers Health Inc (HIMS) is 54.9% below. Put any of them next to TEVA in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Teva Pharma Industries Ltd ADR trade when bond yields rise?

Over the past year Teva Pharma Industries Ltd ADR had a beta of 0.20 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 21% of US names. On the 10 sessions in which long bonds fell most it moved +0.12% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Teva Pharma Industries Ltd ADR do?

Teva makes and sells generic medicines across many dosage forms alongside branded treatments for the nervous system, respiratory illness and cancer, and supplies active ingredients and contract manufacturing to other drugmakers. It licenses products to other pharmaceutical firms and has agreements with partners such as Sanofi and Alvotech. It is headquartered in Tel Aviv and lists in the United States as an ADR, a certificate that lets US investors hold foreign shares. Closelooknet's peer group places it with other scored Healthcare names based in the US, among them Regeneron, Vertex and BeiGene; the market also compares it with fellow generics maker Viatris.

Where does Teva Pharma Industries Ltd ADR sit in the AI build-out?

Teva has no seat in our index, Rubin, which tracks the AI build-out; it belongs to the diary's Healthcare sleeve, the part of our universe covering scored drugmakers rather than compute or chip layers. Teva carries a Closelooknet score built from several modules; momentum reads strongest, quality reads weakest. It holds no seat in our index and has not yet appeared in the diary's editions or quotes.

What has Wall Street done on Teva Pharma Industries Ltd ADR recently?

The most recent analyst action on Teva Pharma Industries Ltd ADR on the Closelooknet wire is a price target by Oppenheimer on 2026-09-23 (target 50). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for TEVA, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.